HIV SYMPTOMS News, Sports, Shopping, Travel information

InternalMDLinx Daily Medical News
InternalMDLinx collects articles from internal medical journals, organized by your specialty, and delivers e-mail newsletters to physicians. Register online for your free daily newsletter.
www.mdlinx.com

Across The Nation | Increased Hiv Prevention, Education Efforts Needed ... - Kaisernetwork.org
officials in martin and indian river counties in florida are calling for increased hiv/aids prevention and education efforts in an attempt to encourage testing and curb the spread of the virus, the south florida sun-sentinel reports. karen thomas, an ...
www.kaisernetwork.org

Uganda: Fighting Hiv/aids For 18 Years
prof elly katabira left a well paying job in england in 1985 just as the hiv/aids crisis was wrecking havoc in war-torn uganda.
allafrica.com

Long-term Study Evaluates Boosted Prezista(r) Vs. Lopinavir/ritonavir As Part Of Hiv Combination Therapy In ...
ninety-six week results presented from a phase 3, randomized, open-label, ongoing clinical trial showed that 79 percent of treatment-naive hiv-1 infected adults taking prezista(r) 800 mg (two 400 mg tablets) with 100 mg ritonavir (r) once daily reached an undetectable viral load (artemis 96-w
www.medicalnewstoday.com

New Phase Iii Study In Previously Untreated Hiv Patients Showed - Msn Moneycentral
in a new phase iii study that compared merck & co., inc.'s hiv integrase inhibitor isentress ® (raltegravir) to efavirenz [ one of the leading antiretrovirals prescribed for previously untreated (treatment-na ï ve) hiv-infected patients ...
news.moneycentral.msn.com

Concert Pharmaceuticals To Present At The Oppenheimer 19th Annual ... - Genetic Engineering News
concert pharmaceuticals, inc. is a clinical stage biotechnology company dedicated to creating medically and commercially important new medicines through a novel approach utilizing the naturally-occurring element deuterium. concert applies its ...
www.genengnews.com

Earlier Hiv Treatment Boosts Survival
hundreds of thousands of lives could be saved if treatment for hiv-infected patients were started earlier than current guidelines suggest, researchers report.
www.webmd.com

Hiv Reports On Treasure Coast May Be Misleading
statistics might not tell the whole truth about hiv and aids on the treasure coast.
www.wptv.com

96-week Data From Castle Study Continue To Show Similar Efficacy - Msn Moneycentral
bristol-myers squibb company bmy today announced 96-week data from the castle study, in which 74 percent of the 440 patients in the reyataz ® (atazanavir sulfate)/r arm achieved an undetectable viral load, defined as hiv-1 rna less than 50 copies/ml ...
news.moneycentral.msn.com

Health Workers In New York State Call For Change In Hiv Testing ... - Medical News Today
some new york state health care workers -- including emergency department workers, paramedics and emts -- are hoping to change a state law that requires written consent prior to hiv testing of patients in the event that health workers experience ...
www.medicalnewstoday.com

Merck, Pfizer Hiv Drugs Match Bristol's First-use Treatment
oct. 26 (bloomberg) -- new drugs from merck & co . and pfizer inc., both approved for use in hiv patients after other treatments fail, showed in separate studies they could also be used for initial treatment of the virus.
www.bloomberg.com

Hiv Reports On Treasure Coast May Be Misleading
statistics might not tell the whole truth about hiv and aids on the treasure coast. martin and indian river counties each report just more than 100 hiv cases since 1997, but health officials say the numbers could be greater, kept artificially low by a population too afraid of or embarrassed by the sexually transmitted disease to get tested. according to health department statistics, ...
tcpalm.com

Bc-staph-infections - Ap - Guardian Unlimited
bc-staph-infections health news up to 2,700 alberta patients to be tested after used syringes used on patients about 2,700 people in a northern alberta community will be tested for communicable diseases because clinic staff were reusing syringes to ...
www.guardian.co.uk

Early Hiv Therapy Improves Survival Cme - Medscape News
physicians - maximum of 0.25 ama pra category 1 credit(s) ™ for physicians; family physicians - up to 0.25 aafp prescribed credit(s) for physicians to participate in this internet activity: (1) review the target audience, learning objectives, and ...
www.medscape.com

Hiv Treatment Should Start Sooner, Study Finds
people who have the aids virus should start drug treatments sooner than current guidelines recommend, suggests a large new study that could change the care of hundreds of thousands of americans.
www.planetout.com

You Are Here:
raltegravir ( isentress ), the new integrase inhibitor manufactured by merck, showed equivalent anti-hiv activity to efavirenz during the first 48 weeks of a large phase iii trial in treatment-naive patients, and those who received raltegravir had greater increases in cd4 counts and fewer central nervous system symptoms, delegates heard at the 48 th interscience conference on antimicrobial ...
www.aidsmap.com

Concert Pharmaceuticals Announces Preclinical Results Suggesting ... - Medical News Today
concert pharmaceuticals, inc. today announced findings from a preclinical study suggesting that c-20081, a novel, deuterium-containing oxazolidinone antibiotic, may be suitable for once-daily oral and intravenous dosing. in the preclinical study, c ...
www.medicalnewstoday.com

Study: Hiv Patients Should Start Drugs Early - San Francisco Gate
monday, october 27, 2008 the study found that delaying treatment until a patient's immune system is badly damaged nearly doubles the risk of dying in the next few years compared with patients whose treatment started earlier. doctors have thought it ...
www.sfgate.com

Antiretroviral Treatment Should Start Earlier, Study Says
people living with hiv should begin antiretroviral treatments earlier than what current guidelines recommend, according to a large new study presented on sunday, the ap/yahoo! news reports.
www.medicalnewstoday.com

New Phase Iii Study In Previously Untreated Hiv Patients Showed Merck's Isentress(r) (raltegravir) Reduced Hiv Viral ...
washington----in a new phase iii study that compared merck & co., inc.'s hiv integrase inhibitor isentress® to efavirenz [one of the leading antiretrovirals prescribed for previously untreated hiv-infected patients ], isentress reduced hiv viral load to undetectable levels in 86 percent of patients compared to 82 percent of patients treated with efavirenz in previously untreated hiv patients at ...
biz.yahoo.com

Early Hiv Treatment Shows 70% Improvement In Survival - Eflux Media
hiv patients who began treatment earlier than is currently recommended lived longer compared to those who followed guidelines, us and canadian researchers found. hiv virus ravages the immune system’s t-cells that fight off germs. once this process ...
www.efluxmedia.com